logo

For the Inventor, By the Inventor

Gentofte, Denmark

Stefan Lutz Richter

This inventor holds 2 USPTO granted patents. Top assignee: Novo Nordisk A/s. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefan Lutz Richter. Retrieved from https://idiyas.com/inventor/stefan-lutz-richter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2

% Patents Active = 100.0

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 50(Granted Patents)


Company Filing History:

goldMedal2 out of 1,802 
 
Novo Nordisk A/s
 patents

Years Active: 1999

Loading Chart...
2 patents (USPTO):Explore Patents
1. 5990084 - Compounds with growth hormone releasing properties (1999-11-23),
2. 5859010 - Factor VII -binding reagent (1999-01-12),

Title: The Innovative Contributions of Stefan Lutz Richter

Introduction

Stefan Lutz Richter is a notable inventor based in Gentofte, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with growth hormone releasing properties. His work has led to the filing of multiple patents, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

Stefan Lutz Richter holds 2 patents that reflect his expertise and innovative approach. His latest patents include:

1. **Compounds with growth hormone releasing properties** - This invention relates to truncated growth hormone receptors (GHRs) of the general formula I.

2. **Factor VII-binding reagent** - This invention pertains to novel compounds that enhance zinc ion inhibition of the activity of factor VIIa or the tissue factor-factor VIIa complex, represented by the formulas Ia and Ib. It also includes pharmaceutical salts and compositions that utilize these novel compounds for inhibiting clotting activity, tissue factor activity, and factor VIIa activity.

Career Highlights

Stefan Lutz Richter is currently associated with Novo Nordisk A/S, a leading global healthcare company. His role at Novo Nordisk allows him to contribute to groundbreaking research and development in the pharmaceutical industry. His work is instrumental in creating innovative solutions that address critical health challenges.

Collaborations

Stefan has collaborated with esteemed colleagues such as Ole Hvilsted Olsen and Kjeld Madsen. These collaborations have further enriched his research and contributed to the success of his innovative projects.

Conclusion

Stefan Lutz Richter's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence advancements in medical science and improve healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…